# Americas Safety Lancet Market

> Americas Safety Lancet Market by Product Type (Push Button Safety Lancet, Side Button Safety Lancet, and Pressure Activated Safety Lancet), By Application (Glucose Testing, Hemoglobin Testing, Coagulation Testing, Cholesterol Testing, Allergy Testing, Neonatal Screening, and Others), By End User (Hospitals & Clinics, Ambulatory Surgery Centers, and Home Care Setting) and Region (North America & South America) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 9.89%
- **2024:** $ 1.01 Billion
- **2025:** $ 1.11 Billion
- **2035:** $ 2.85 Billion
- **Key Players:** BD (US), Terumo Corporation (JP), Roche Diagnostics (CH), Abbott Laboratories (US), F. Hoffmann-La Roche AG (CH), Medtronic (US), B. Braun Melsungen AG (DE), Sanofi (FR), Johnson & Johnson (US)

**Report ID:** MRFR/MED/0131-HCR · **Pages:** 110 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/americas-safety-lancet-market-574

---

## Market Summary

## **Americas Safety Lancet Market Overview**

The Americas Safety Lancet was valued at USD 0.96 billion in 2023 and is projected to grow from USD 1.01 billion in 2024 to USD 1.82 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.89% during the forecast period (2024 – 2032). Increase in the prevalence of chronic disease such as diabetes and rise in prevention of needlestick injuries are the major factors driving the growth of market.

Source: Secondary Research, Primary Research, _Market Research Future_ Database, and Analyst Review

## **Americas Safety Lancet Market Trends**

**Rising Prevalence of Diabetes**

Ride in prevalence of diabetes is the major factor that drives the growth of market. Diabetes is a chronic condition that affects millions of people globally, and regular [blood glucose monitoring](../../../reports/blood-glucose-monitoring-market-557) is essential for managing the disease.

Safety lancets are commonly used for blood sampling in diabetic patients, as they provide a convenient and painless way to collect blood samples for glucose monitoring. Unlike traditional lancets, safety lancets have a built-in safety mechanism that reduces the risk of needlestick injuries and contamination, making them a safer option for patients and healthcare providers.

According to CDC report, in 2021, around 38.4 million people - 11.6% of US population - had diabetes, out of which, 29.7 million people of all ages had diagnosed diabetes and 8.7 million people (22.8% of adults are with diabetes) are undiagnosed. 1.7 million adults aged 20 years or older with diagnosed diabetes reported having type 1 diabetes and relying on insulin for treatment.

As the prevalence of diabetes continues to rise, the demand for safety lancets is also expected to increase. Additionally, technological advancements in safety lancet design and the introduction of innovative features such as retractable needles and automatic release mechanisms are further driving market growth.

## **Americas Safety Lancet Segment Insights**

### **Americas Safety Lancet Product Type Insights**

Based on Type, the market is segmented into Push Button Safety Lancet, Pressure Activated Safety Lancet, Side Button Safety Lancet. The push-button safety lancet held the largest share in the Americas safety lancet market because of its ease of use and convenience for healthcare professionals and patients. These safety lancets have a simple push-button mechanism that allows for quick and easy activation, reducing the risk of accidental needlestick injuries. Additionally, push-button safety lancets typically have adjustable depth settings, allowing for proper customization for each individual's skin type and blood draw requirements.

Overall, the push-button safety lancet is a popular choice in the market due to its user-friendly design and safety features.

**FIGURE 2: AMERICAS SAFETY LANCET SIZE, BY PRODUCT TYPE, 2023 & 2032 (USD BILLION)**

****

Source: Secondary Research, Primary Research, _Market Research Future_ Database, and Analyst Review

### **Americas Safety Lancet Application Insights**

Based on the Application, The Americas Safety Lancet includes Glucose Testing, Hemoglobin Testing, Coagulation Testing, Cholesterol Testing, Allergy Testing, Neonatal Screening, and Others.

Among these, Glucose testing held the largest share in the Americas safety lancet market because it is a common and essential procedure for diabetics to monitor their blood sugar levels regularly. Safety lancets are used to draw blood quickly and safely for glucose testing, making them a necessary tool for diabetics. With the increasing prevalence of diabetes worldwide, the demand for safety lancets for glucose testing is expected to continue to grow, leading to their dominant share in the market.

Additionally, the convenience and ease of use provided by safety lancets have also contributed to their widespread adoption among healthcare professionals and patients.

### **Americas Safety Lancet End-User Insights**

The market segments of Americas Safety Lancet based on End-Users includes Hospitals & Clinics, Ambulatory Surgery Centers, and Home Care Setting. The Hospitals & Clinics segment held the majority of the market and is the fastest-growing segment during the forecast year due to the growing demand for frequent glucose testing, hemoglobin testing, cholesterol testing, allergy testing, coagulation testing, and neonatal screening across the region is driving the growth of market.

### **Americas Safety Lancet Regional Insights**

By Region, the market is bifurcated into North America and South America. North America held the largest share in the Americas safety lancet market due to a well-established healthcare infrastructure with high healthcare expenditure, leading to greater adoption of safety lancets in the region. Additionally, the presence of key market players and advancements in healthcare technology are also contributing factors. Moreover, strict regulations and initiatives promoting safe healthcare practices in the region have further fueled the demand for safety lancets. Overall, these factors have collectively contributed to North America holding the largest share in the safety lancet market.

South America is experiencing the fastest growth in the safety lancet market due to several factors. One of the key reasons for this growth is the increasing awareness and importance of blood glucose monitoring in the region. With the rising prevalence of diabetes and other chronic conditions in South America, there is a growing demand for safe and convenient ways to collect blood samples for testing. Safety lancets provide an easy and painless solution for individuals to monitor their blood glucose levels regularly.

Additionally, the growing healthcare infrastructure in South America and the increasing adoption of advanced medical technologies have also contributed to the rapid growth of the safety lancet market in the region. Healthcare providers are increasingly using safety lancets in hospitals, clinics, and other healthcare facilities to ensure the safety of patients and healthcare workers during blood sample collection.

Overall, the combination of increasing awareness about the importance of blood glucose monitoring, improving healthcare infrastructure, and the availability of advanced safety lancet products has made South America the fastest growing market for safety lancets. As the demand for these devices continues to rise, the safety lancet market in the region is expected to further expand in the coming years.

**FIGURE 3: AMERICAS SAFETY LANCET SIZE, BY REGION, 2023 & 2032 (USD BILLION)**

****

Source: Secondary Research, Primary Research, _Market Research Future_ Database, and Analyst Review

**Americas Safety Lancet Key Market Players & Competitive Insights**

The Americas Safety Lancet is marked by the presence of numerous global, regional, and local vendors catering to the demands of a large patient population affected by conditions like diabetes and infectious diseases. This market is highly competitive, with companies both competing and cooperating to capture a significant share. Key drivers of growth include expanding into new, unexplored markets, launching innovative products, forging strategic partnerships, and implementing measures to enhance operational efficiency. Market players employ diverse strategies and advanced research and development techniques to expand their market presence and ensure sustainability.

Mergers and collaborations were also observed to expand the company's product portfolio, as well as introduce new safety lancets. The growth of prominent industry players is dependent on various factors, such as market conditions, FDA approvals, and industry development. It is also projected that a rise in the investments for R&D will also boost the market's growth in the upcoming future.

Major players in the Americas Safety Lancet Market, including Becton, Dickinson and Company, Inc, Dynarex Corporation, Abbott Laboratories, ICU Medical, Inc., Cardinal Health, LifeScan IP Holdings, LLC, and others, are making investments in R&D activities to boost market demand.

In recent years, major players have increasingly engaged in strategic collaborations for product development and geographical expansion into untapped markets to achieve operational excellence and strengthen their market positions in the Americas safety lancet market.

**Americas Safety Lancet Industry Developments**

**September 2022:** Tasso has obtained 510(k) clearance for its blood lancet, allowing the company to introduce a device aimed at fulfilling the growing need for remote testing services. Known as Tasso+, this product is engineered to facilitate blood collection in home settings. Users simply adhere the device to their arm and activate it by pressing a button, which deploys a lancet and starts the blood collection process.

**In January 2024,** the Commission on Primary Health Care (PHC) and Resilience in Latin America and the Caribbean (LAC) was established in January 2024 by the Lancet Americas, the World Bank, and the Pan American Health Organization (PAHO). Its primary objectives are as follows: establish a comprehensive conceptual policy framework for PHC and resilience; identify and define the key investments that LAC countries could undertake; and conduct a thorough assessment of the foreseen consequences. As commissioners, a multidisciplinary group comprising experts, managers, policymakers, and civil society leaders will strive to guarantee substantial technical knowledge, gender parity, and LAC representation.

In November 2023, the Medtronic Symplicity Spyral™ renal denervation system was granted approval by the U.S. Food and Drug Administration (FDA) for distribution within the United States. The system, which has been granted the Breakthrough Device designation by the FDA, disrupts hyperactive neurons in the kidneys via radio frequency in order to assist in the reduction of blood pressure.

There are now, for the first time, medical device-related procedures that have received approval for the treatment of hypertension in the United States.  Particularly for those patients whose hypertension does not respond to medication or who have difficulty adhering to their medication regimen, Symplicity Spyral possesses the capacity to significantly impact their lifestyles. When combined with pharmacological interventions and modifications to one's lifestyle, renal denervation presents a viable and secure alternative for the long-term management of hypertension.

The lancet market is significantly driven by the increasing incidence of infectious and chronic diseases, enhanced medical device regulations, growing preference for home healthcare, and the rising prevalence of diabetes. 

**Key Players in Americas Safety Lancet Market**

**Key Companies in the Americas Safety Lancet include**

## **Americas Safety Lancet Market Segmentation**

### **By Type**

### **By End-User**

**Factors driving this growth include:**

In the end, the report introduced medical suction device market SWOT analysis, PEST analysis, market share analysis and competitive landscape, company profiles by analyzing the major players. It is a depth research study on Safety Lancet. We are thankful for the support and assistance from Safety Lancet. industry chain related technical experts and marketing experts during Research Team survey and interviews.

## Market Drivers

### Focus on Patient Safety

Patient safety remains a critical concern within healthcare settings, driving the Americas Safety Lancet Market. The emphasis on reducing healthcare-associated infections and needle-stick injuries has led to increased adoption of safety lancets. Healthcare facilities are increasingly implementing protocols that prioritize the use of safety-engineered devices to protect both patients and healthcare workers. This shift is supported by various health organizations advocating for safer medical practices. The market is projected to grow as hospitals and clinics invest in safety lancets that comply with stringent safety regulations. The commitment to enhancing patient safety is likely to foster innovation and development within the Americas Safety Lancet Market.

### Regulatory Support and Compliance

Regulatory frameworks play a pivotal role in shaping the Americas Safety Lancet Market. Government agencies are increasingly mandating the use of safety-engineered devices to mitigate risks associated with needle-stick injuries. Compliance with these regulations is driving manufacturers to innovate and produce safer products. The introduction of guidelines that promote the use of safety lancets in both clinical and home settings is likely to expand the market. As healthcare providers strive to meet regulatory requirements, the demand for compliant safety lancets is expected to grow. This regulatory support is crucial for fostering a safer healthcare environment and enhancing the overall market landscape.

### Growing Awareness of Diabetes Management

The increasing awareness surrounding diabetes management is a significant driver for the Americas Safety Lancet Market. With a substantial portion of the population diagnosed with diabetes, there is a heightened focus on effective self-monitoring practices. Safety lancets are essential tools for individuals managing their blood glucose levels, as they provide a safer alternative to traditional lancets. Educational initiatives aimed at promoting diabetes awareness are likely to boost the adoption of safety lancets among patients. As more individuals recognize the importance of regular monitoring, the demand for safety lancets is expected to rise, thereby positively impacting the Americas Safety Lancet Market.

### Increasing Prevalence of Chronic Diseases

The rising incidence of chronic diseases such as diabetes and cardiovascular conditions is a notable driver for the Americas Safety Lancet Market. As these diseases require regular monitoring of blood glucose and other vital parameters, the demand for safety lancets is expected to surge. According to recent data, approximately 34 million Americans are living with diabetes, which translates to a significant market opportunity for safety lancets. The need for safe and effective blood sampling devices is paramount, as they minimize the risk of needle-stick injuries and enhance patient compliance. This trend indicates a growing awareness among healthcare providers and patients regarding the importance of using safety devices, thereby propelling the Americas Safety Lancet Market forward.

### Technological Innovations in Device Design

Technological advancements in the design and functionality of safety lancets are significantly influencing the Americas Safety Lancet Market. Innovations such as automatic retractable needles and improved ergonomics are enhancing user experience and safety. These advancements not only reduce the risk of accidental needle-stick injuries but also improve the accuracy of blood sampling. The integration of smart technology, such as connectivity features for data tracking, is also emerging as a trend. As healthcare providers seek more efficient and user-friendly devices, the demand for technologically advanced safety lancets is expected to rise. This trend indicates a shift towards more sophisticated solutions within the Americas Safety Lancet Market.

## Future Outlook

The Americas Safety Lancet Market is projected to grow at a 9.89% CAGR from 2025 to 2035, driven by increasing healthcare demands and technological advancements.

**New opportunities:**

- Expansion of telehealth services for remote patient monitoring. Development of eco-friendly safety lancets to meet sustainability goals. Integration of smart technology in lancets for enhanced user experience.

By 2035, the market is expected to achieve robust growth, positioning itself as a leader in healthcare innovation.

## Segment Insights

### By Type: Push Button Safety Lancet (Largest) vs. Pressure Activated Safety Lancet (Fastest-Growing)

In the Americas Safety Lancet Market, the Push Button Safety Lancet holds a significant portion of the market share, distinguishing itself as the largest segment due to its user-friendly design and reliability in various clinical settings. This segment caters to patient safety and convenience, which are paramount in medical environments, securing its position as the preferred choice among healthcare providers. The Pressure Activated Safety Lancet, while currently comprising a smaller market share, is gaining traction as it offers speed and efficiency in procedures, appealing particularly to the burgeoning demand for quick and safe blood collection methods during patient assessments.

Push Button Safety Lancet (Dominant) vs. Pressure Activated Safety Lancet (Emerging)

The Push Button Safety Lancet is characterized by its intuitive mechanism that enhances user experience and reduces the risk of needle-stick injuries, making it highly favored in hospitals and clinics. Its dominance in the market is bolstered by strong endorsements from healthcare practitioners who appreciate the design's safety features and ease of use. Conversely, the Pressure Activated Safety Lancet presents an emerging option, known for its rapid deployment and minimal time required for blood sample collection. As healthcare providers increasingly prioritize efficiency, this segment is witnessing significant innovation, aiming to meet the rising demands for comfortable and safe patient care.

### By Application: Glucose Testing (Largest) vs. Coagulation Testing (Fastest-Growing)

The Americas Safety Lancet Market showcases a diverse application range, with glucose testing holding the largest market share due to its widespread use in diabetes management practices. Hemoglobin and cholesterol testing follow closely, while coagulation testing has recently gained traction. Allergy testing, neonatal screening, and other applications feature lesser shares but contribute to the market's diversity. As the focus on preventive healthcare rises, driving factors include an increase in diabetes incidences, a growing aging population, and technological advancements in testing devices. Coagulation testing, in particular, has emerged due to increased awareness of blood disorders, making it one of the fastest-growing segments. The market is poised for growth, reflecting improving healthcare infrastructure and policies in the Americas.

Glucose Testing (Dominant) vs. Coagulation Testing (Emerging)

Glucose testing sits at the forefront of the Americas Safety Lancet Market, driven by the prevalence of diabetes and related conditions. Its established protocols and widespread acceptance in various health settings make it a dominant player. Conversely, coagulation testing, while newer and less established, is gaining market share rapidly. This growth can be attributed to an increase in the diagnosis of bleeding disorders and advancements in technology that allow for quicker, simpler testing methods. As healthcare providers aim for efficiency and accuracy, these two applications represent a critical cross-section of established reliability and innovative growth in the market.

### By End-User: Hospitals & Clinics (Largest) vs. Home Care Setting (Fastest-Growing)

In the Americas Safety Lancet Market, Hospitals & Clinics hold the largest share of the end-user segment, reflecting their critical role in patient care and safety. This segment benefits from high volumes of procedures and a continua lneed for safe blood collection practices. Conversely, the Home Care Setting is witnessing a surge in adoption due to an increase in chronic diseases and a shift towards more personalized healthcare services.

Hospitals & Clinics (Dominant) vs. Home Care Setting (Emerging)

The Hospitals & Clinics segment stands as the dominant force in the Americas Safety Lancet Market, attributed to their extensive usage of safety devices to minimize risk during blood sampling. These facilities are also equipped with trained staff and advanced medical technologies, enhancing safety and efficiency. On the other hand, the Home Care Setting is emerging rapidly, driven by an aging population and a preference for cost-effective healthcare solutions. Patients prefer performing blood tests at home, which not only ensures convenience but also fosters adherence to treatment plans. Both segments illustrate the diverse application and growing importance of safety lancets in enhancing patient care.

## Regional Market Share Analysis

### North America : Market Leader in Safety Lancets

North America is the largest market for safety lancets, accounting for approximately 45% of the global market share. The region's growth is driven by increasing diabetes prevalence, rising awareness of safety devices, and stringent regulatory frameworks. The U.S. leads this market, followed closely by Canada, which holds about 15% of the market share. Regulatory support from agencies like the FDA further catalyzes innovation and adoption of safety lancets. The competitive landscape in North America is robust, featuring key players such as BD, Abbott Laboratories, and Johnson & Johnson. These companies are investing heavily in R&D to enhance product offerings and meet the growing demand for safer medical devices. The presence of advanced healthcare infrastructure and a high rate of diabetes management also contribute to the region's market strength.

### Europe : Emerging Market Dynamics

Europe is witnessing significant growth in the safety lancet market, holding approximately 30% of the global share. The region benefits from increasing healthcare expenditure, a rising elderly population, and a growing focus on patient safety. Germany and France are the largest markets, with Germany accounting for about 12% of the market. Regulatory initiatives aimed at improving medical device safety are also propelling market growth across the continent. Leading countries in Europe include Germany, France, and the UK, with a competitive landscape featuring major players like Roche Diagnostics and Sanofi. The presence of established healthcare systems and a strong emphasis on innovation are driving the market forward. Companies are focusing on product differentiation and strategic partnerships to enhance their market position and meet evolving consumer needs.

### Asia-Pacific : Rapidly Growing Market Potential

The Asia-Pacific region is emerging as a significant player in the safety lancet market, currently holding about 20% of the global share. Factors such as rising healthcare awareness, increasing diabetes cases, and government initiatives to improve healthcare access are driving this growth. China and India are the largest markets, with China alone accounting for approximately 10% of the market share, supported by a growing middle class and urbanization trends. The competitive landscape in Asia-Pacific is evolving, with both local and international players vying for market share. Companies like Terumo Corporation and Medtronic are expanding their presence through strategic collaborations and product innovations. The region's diverse healthcare needs and varying regulatory environments present both challenges and opportunities for market participants, making it a dynamic landscape for safety lancets.

### Middle East and Africa : Untapped Market Opportunities

The Middle East and Africa (MEA) region is gradually emerging in the safety lancet market, currently holding about 5% of the global share. The growth is driven by increasing healthcare investments, rising awareness of diabetes management, and government initiatives aimed at improving healthcare infrastructure. Countries like South Africa and the UAE are leading the market, with South Africa accounting for approximately 3% of the market share, supported by a growing focus on chronic disease management. The competitive landscape in MEA is characterized by a mix of local and international players, with companies like B. Braun Melsungen AG and F. Hoffmann-La Roche AG making significant inroads. The region's diverse healthcare challenges and varying regulatory frameworks present unique opportunities for innovation and market entry, making it an attractive area for investment in safety lancets.

## Competitive Benchmarking

The Americas Safety Lancet Market is characterized by a dynamic competitive landscape, driven by a confluence of innovation, regulatory compliance, and an increasing emphasis on patient safety. Key players such as BD (US), Terumo Corporation (JP), and Abbott Laboratories (US) are at the forefront, each adopting distinct strategies to enhance their market positioning. BD (US) has focused on expanding its product portfolio through innovation, particularly in safety-engineered devices, which aligns with the growing demand for safer medical practices. Terumo Corporation (JP) emphasizes regional expansion and strategic partnerships, enhancing its distribution networks across North America. Meanwhile, Abbott Laboratories (US) is leveraging digital transformation to improve patient outcomes and streamline operations, indicating a shift towards technology-driven healthcare solutions. Collectively, these strategies contribute to a competitive environment that is increasingly focused on safety, efficiency, and technological advancement.In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance responsiveness to market demands. The competitive structure of the Americas Safety Lancet Market appears moderately fragmented, with several key players exerting influence while also facing competition from smaller, specialized firms. This fragmentation allows for diverse product offerings and innovation, as companies strive to differentiate themselves in a crowded marketplace.
In August BD (US) announced the launch of a new safety lancet designed to minimize the risk of needlestick injuries, a move that underscores its commitment to patient safety and innovation. This strategic action not only enhances BD's product portfolio but also positions the company as a leader in addressing critical healthcare challenges. The introduction of this device is likely to resonate well with healthcare providers seeking to improve safety protocols in clinical settings.
In September Terumo Corporation (JP) entered into a strategic partnership with a leading telehealth provider to integrate its safety lancet products into remote patient monitoring systems. This collaboration is indicative of a broader trend towards digital health solutions, suggesting that Terumo is keen on leveraging technology to enhance patient care and expand its market reach. Such partnerships may facilitate the adoption of safety lancets in telehealth applications, thereby broadening their utility and market penetration.
In October Abbott Laboratories (US) unveiled a new digital platform aimed at healthcare professionals, providing real-time data analytics on the use of safety lancets. This initiative reflects Abbott's focus on integrating artificial intelligence and data analytics into its product offerings, potentially transforming how healthcare providers manage patient safety. By equipping professionals with actionable insights, Abbott is likely to enhance the value proposition of its safety lancet products, fostering greater adoption in clinical environments.
As of October the competitive trends in the Americas Safety Lancet Market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are becoming pivotal, as companies recognize the need to collaborate to enhance their technological capabilities and market reach. Looking ahead, competitive differentiation is expected to evolve, with a pronounced shift from price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This transition may ultimately redefine the parameters of success in the market, as companies strive to meet the evolving needs of healthcare providers and patients.

## Recent News & Developments

**September 2022:** Tasso has obtained 510(k) clearance for its blood lancet, allowing the company to introduce a device aimed at fulfilling the growing need for remote testing services. Known as Tasso+, this product is engineered to facilitate blood collection in home settings. Users simply adhere the device to their arm and activate it by pressing a button, which deploys a lancet and starts the blood collection process.

**In January 2024,** the Commission on Primary Health Care (PHC) and Resilience in Latin America and the Caribbean (LAC) was established in January 2024 by the Lancet Americas, the World Bank, and the Pan American Health Organization (PAHO). Its primary objectives are as follows: establish a comprehensive conceptual policy framework for PHC and resilience; identify and define the key investments that LAC countries could undertake; and conduct a thorough assessment of the foreseen consequences. As commissioners, a multidisciplinary group comprising experts, managers, policymakers, and civil society leaders will strive to guarantee substantial technical knowledge, gender parity, and LAC representation.

In November 2023, the Medtronic Symplicity Spyral™ renal denervation system was granted approval by the U.S. Food and Drug Administration (FDA) for distribution within the United States. The system, which has been granted the Breakthrough Device designation by the FDA, disrupts hyperactive neurons in the kidneys via radio frequency in order to assist in the reduction of blood pressure.

There are now, for the first time, medical device-related procedures that have received approval for the treatment of hypertension in the United States.  Particularly for those patients whose hypertension does not respond to medication or who have difficulty adhering to their medication regimen, Symplicity Spyral possesses the capacity to significantly impact their lifestyles. When combined with pharmacological interventions and modifications to one's lifestyle, renal denervation presents a viable and secure alternative for the long-term management of hypertension.

The lancet market is significantly driven by the increasing incidence of infectious and chronic diseases, enhanced medical device regulations, growing preference for home healthcare, and the rising prevalence of diabetes. 

**Key Players in Americas Safety Lancet Market**

**Key Companies in the Americas Safety Lancet Market include**

- Becton, Dickinson and Company
- Dynarex Corporation
- Abbott Laboratories
- LifeScan IP Holdings, LLC
- ICU Medical, Inc.
- Cardinal Health
- Simple Diagnostics
- Medline Industries, LP.
- McKesson Medical-Surgical Inc.
- [Trividia Health, Inc.](https://www.trividiahealth.com/products/sharps/true-plus-safety-lancets/)
- Tasso, Inc.

## Report Scope

| MARKET SIZE 2024 | 1.01(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 1.11(USD Billion) |
| MARKET SIZE 2035 | 2.851(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 9.89% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | BD (US), Terumo Corporation (JP), Roche Diagnostics (CH), Abbott Laboratories (US), F. Hoffmann-La Roche AG (CH), Medtronic (US), B. Braun Melsungen AG (DE), Sanofi (FR), Johnson & Johnson (US) |
| Segments Covered | Product Type, Application, End User |
| Key Market Opportunities | Integration of advanced safety features in lancets to enhance user experience and compliance. |
| Key Market Dynamics | Rising demand for safety lancets driven by regulatory changes and increasing consumer awareness of diabetes management. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the projected market valuation of the Americas Safety Lancet Market by 2035?**
A: The projected market valuation for the Americas Safety Lancet Market is 2.851 USD Billion by 2035.

**Q: What was the market valuation of the Americas Safety Lancet Market in 2024?**
A: The overall market valuation was 1.01 USD Billion in 2024.

**Q: What is the expected CAGR for the Americas Safety Lancet Market during the forecast period 2025 - 2035?**
A: The expected CAGR for the Americas Safety Lancet Market during the forecast period 2025 - 2035 is 9.89%.

**Q: Which companies are considered key players in the Americas Safety Lancet Market?**
A: Key players in the market include BD (US), Terumo Corporation (JP), Roche Diagnostics (CH), and Abbott Laboratories (US), among others.

**Q: What are the main types of safety lancets in the Americas market?**
A: The main types of safety lancets include Push Button Safety Lancet, Pressure Activated Safety Lancet, and Side Button Safety Lancet.

**Q: How did the Push Button Safety Lancet segment perform in 2024?**
A: In 2024, the Push Button Safety Lancet segment was valued at 0.404 USD Billion.

**Q: What is the projected value of the Hemoglobin Testing application by 2035?**
A: The projected value of the Hemoglobin Testing application is expected to reach 0.45 USD Billion by 2035.

**Q: Which end-user segment had the highest valuation in 2024?**
A: In 2024, the Hospitals & Clinics end-user segment had the highest valuation at 0.505 USD Billion.

**Q: What is the expected growth trend for the Allergy Testing application from 2024 to 2035?**
A: The Allergy Testing application is projected to grow from 0.05 USD Billion in 2024 to 0.15 USD Billion by 2035.

**Q: How does the market for Safety Lancets in Home Care Settings compare to other end-user segments?**
A: The Home Care Setting segment is projected to grow from 0.202 USD Billion in 2024, indicating a smaller market compared to Hospitals & Clinics.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/americas-safety-lancet-market-574*